341 results
SD
EX-1.01
BAX
Baxter International Inc.
31 May 24
Conflict minerals disclosure
8:10am
with works councils), or the inability to attract, develop, retain, and engage employees; product quality or patient safety issues leading to product
8-K
EX-99.1
BAX
Baxter International Inc.
2 May 24
Baxter Reports First-quarter 2024 Results
7:17am
and Dose IQ Safety Software advances connected and intelligent infusion therapy portfolio
DEERFIELD, Ill., MAY 2, 2024 – Baxter International Inc … :
Announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Novum IQ large volume infusion pump (LVP) with Dose IQ Safety Software
8-K
EX-99.1
kitb97
8 Feb 24
Baxter Reports Fourth-quarter and Full-year 2023 Results
7:18am
8-K
EX-99.1
qsrrey
2 Nov 23
Baxter Reports Third-quarter 2023 Results
7:18am
8-K
EX-99.1
wrosd mov2p39u
27 Jul 23
Baxter Reports Second-quarter 2023 Results
7:33am
8-K
EX-99.1
llhy n2wu6l8qn
6 Jul 23
Regulation FD Disclosure
8:30am
SD
EX-1.01
wk8lnhpv
31 May 23
Conflict minerals disclosure
4:36pm
8-K
EX-2.1
2pdz5d8vb zlxehbqlo
9 May 23
Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to
8:42am
8-K
EX-3.1
wfgt kbbd
9 May 23
Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to
8:42am
8-K
EX-99.1
0km3fexp
27 Apr 23
Baxter Reports First-quarter 2023 Results
7:18am
8-K
EX-99.1
bm5q dpbmb8cxh6lu
27 Oct 22
Baxter Reports Third-quarter 2022 Results
7:18am
8-K
EX-99.1
aktnx
30 Sep 22
Entry into a Material Definitive Agreement
4:16pm